NLP-198

N/A

Report date: 2025/01/15 11:27:04
NME

Base Information

Drug NameNLP-198
Drug Alias NameNLP-198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovalead Pharma Private Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovalead Pharma Private Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A